The Food and Drug Administration has approved the first direct generic competitor to the EpiPen, according to NBC News.
This sets the stage for cheaper competition that may lower prices.
According to NBC News, the new generic drug will be made by an Israeli generic manufacturer and will have a different name.
TRENDING NOW:
It was approved after the FDA issued new guidelines for generic copies of drugs like the EpiPen.
[ Click here to watch a full report from Channel 11's Lori Houy. ]